BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.62B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 3 |
iShares Biotechnology ETF
IBB
|
+$563M |
| 4 |
Bank of America
BAC
|
+$478M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$156M |
| 2 |
AT&T
T
|
+$148M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$126M |
| 4 |
Verizon
VZ
|
+$117M |
| 5 |
Johnson & Johnson
JNJ
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.07% |
| 2 | Financials | 8.49% |
| 3 | Consumer Discretionary | 6.41% |
| 4 | Industrials | 6.25% |
| 5 | Healthcare | 5.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMT
1401
DELISTED
Chemtura Corporation
CHMT
| $274K | ﹤0.01% |
10,045
+3,673
| +58% | +$90.8K |
|
1402
Idacorp
IDA
$8.14B
| $269K | ﹤0.01% |
+4,283
| New | +$275K |
|
|
CPL
1403
DELISTED
CPFL Energia S.A.
CPL
| $267K | ﹤0.01% |
22,209
+7,626
| +52% | +$91.3K |
|
|
CIE
1404
DELISTED
Cobalt International Energy, Inc
CIE
| $265K | ﹤0.01% |
1,875
-11,036
| -85% | -$1.49M |
|
1405
Kite Realty
KRG
$5.31B
| $264K | ﹤0.01% |
9,375
+5,569
| +146% | +$162K |
|
|
AWH
1406
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $262K | ﹤0.01% |
6,493
-22,109
| -77% | -$876K |
|
|
ICPT
1407
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $259K | ﹤0.01% |
919
+903
| +5,644% | +$196K |
|
1408
Northwest Natural Holdings
NWN
$2.13B
| $257K | ﹤0.01% |
5,363
+2,357
| +78% | +$114K |
|
1409
Synopsys
SNPS
$79.5B
| $256K | ﹤0.01% |
5,537
+2,471
| +81% | +$111K |
|
1410
Perdoceo Education
PRDO
$2B
| $256K | ﹤0.01% |
50,808
-37,668
| -43% | -$218K |
|
|
HYI
1411
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
| $255K | ﹤0.01% |
15,587
-56,960
| -79% | -$907K |
|
1412
Mohawk Industries
MHK
$9.45B
| $255K | ﹤0.01% |
1,371
-34,961
| -96% | -$6.05M |
|
1413
Lamar Advertising Co
LAMR
$15.8B
| $254K | ﹤0.01% |
4,290
+2,651
| +162% | +$151K |
|
|
PGRE
1414
DELISTED
Paramount Group
PGRE
| $254K | ﹤0.01% |
13,173
+6,080
| +86% | +$116K |
|
|
UN
1415
DELISTED
Unilever NV New York Registry Shares
UN
| $253K | ﹤0.01% |
6,070
-9,760
| -62% | -$409K |
|
|
CADE
1416
DELISTED
Cadence Bank
CADE
| $253K | ﹤0.01% |
+10,897
| New | +$238K |
|
|
IPXL
1417
DELISTED
Impax Laboratories, Inc.
IPXL
| $253K | ﹤0.01% |
5,392
+3,939
| +271% | +$157K |
|
1418
LPL Financial
LPLA
$29.4B
| $253K | ﹤0.01% |
5,761
+1,587
| +38% | +$70.1K |
|
|
FNSR
1419
DELISTED
Finisar Corp
FNSR
| $253K | ﹤0.01% |
11,838
+7,442
| +169% | +$152K |
|
1420
Travere Therapeutics
TVTX
$5.77B
| $252K | ﹤0.01% |
10,499
+499
| +5% | +$7.61K |
|
1421
Wintrust Financial
WTFC
$10.9B
| $251K | ﹤0.01% |
5,267
+3,037
| +136% | +$140K |
|
|
AF
1422
DELISTED
Astoria Financial Corporation
AF
| $251K | ﹤0.01% |
+19,369
| New | +$249K |
|
1423
Andersons Inc
ANDE
$2.22B
| $250K | ﹤0.01% |
6,049
-550
| -8% | -$24.7K |
|
|
AMED
1424
DELISTED
Amedisys
AMED
| $250K | ﹤0.01% |
9,341
-12,020
| -56% | -$339K |
|
1425
First Horizon
FHN
$12.3B
| $250K | ﹤0.01% |
17,462
+1,413
| +9% | +$19.5K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2015 Portfolio in Review
As of Q1 2015, BNP Paribas Financial Markets held 3,714 positions worth $36.1B, up 28% from $28.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
BNP Paribas Financial Markets deployed $6.48B of net new capital in Q1 2015, opening 1,715 new positions and adding to 1,001 existing holdings. Its largest new stake was State Street SPDR S&P Retail ETF: 3,604,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Potash Corp Of Saskatchewan, an estimated $156M trimmed.
- BNP Paribas Financial Markets's largest Q1 2015 buy was State Street SPDR S&P Retail ETF: 3,604,020 shares worth $182M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q1 2015, an estimated $1.62B increase.
- BNP Paribas Financial Markets's biggest Q1 2015 reduction was Potash Corp Of Saskatchewan, cutting an estimated $156M.
- BNP Paribas Financial Markets fully exited Allergan Inc in Q1 2015, selling an estimated $98.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 39% of its $36.1B portfolio in Q1 2015.
- BNP Paribas Financial Markets opened 1,715 new positions and closed 104 in Q1 2015.
- BNP Paribas Financial Markets's portfolio value rose 28% quarter-over-quarter to $36.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2015, filed 15 May 2015.